Literature DB >> 4629201

Production and degradation of serogroup B Neisseria meningitidis polysaccharide.

P C Maloney, H Schneider, B L Brandt.   

Abstract

Polysaccharide produced from cultures of serogroups A, B, and C Neisseria meningitidis was assayed by the serogroup-specific hemagglutination inhibition (HAI) test. The polysaccharide produced by all serogroups was found to increase during the exponential phase of growth. For serogroups A and C, the HAI activity was stable during the stationary phase; for serogroup B, however, the HAI decayed rapidly. The degradation of the serogroup B polysaccharide was not caused by enzymatic degradation, but was due to acid accumulation in the culture medium. The large-molecular-size serogroup B polysaccharide was stabilized by increasing the buffering capacity of the medium, which also increased the yield of this antigen.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4629201      PMCID: PMC422590          DOI: 10.1128/iai.6.5.657-661.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  The effect of variation in molecular weight on the antigenicity of dextran in man.

Authors:  E A KABAT; A E BEZER
Journal:  Arch Biochem Biophys       Date:  1958-12       Impact factor: 4.013

2.  The specific hapten of group C (group II alpha) meningococcus. I. Preparation and immunological behavior.

Authors:  R G WATSON; H W SCHERP
Journal:  J Immunol       Date:  1958-10       Impact factor: 5.422

3.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man.

Authors:  M S Artenstein; R Gold; J G Zimmerly; F A Wyle; W C Branche; C Harkins
Journal:  J Infect Dis       Date:  1970-04       Impact factor: 5.226

7.  Serologic studies of meningococcal infection and polysaccharide vaccination.

Authors:  M S Artenstein; B L Brandt; E C Tramont; W C Branche; H D Fleet; R L Cohen
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

8.  Quantitative determination of the human immune response to immunization with meningococcal vaccines.

Authors:  E C Gotschlich; M Rey; R Triau; K J Sparks
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide.

Authors:  T Y Liu; E C Gotschlich; F T Dunne; E K Jonssen
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

10.  Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharide.

Authors:  T Y Liu; E C Gotschlich; E K Jonssen; J R Wysocki
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

View more
  10 in total

1.  Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.

Authors:  G Raponi; N Keller; B P Overbeek; M Rozenberg-Arska; K P van Kessel; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

2.  Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

3.  Latex agglutination, counterimmunoelectrophoresis, and protein A co-agglutination in diagnosis of bacterial meningitis.

Authors:  S I Dirks-Go; H C Zanen
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

4.  Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli.

Authors:  C Vermeulen; A Cross; W R Byrne; W Zollinger
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide.

Authors:  J Colino; I Outschoorn
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.

Authors:  W D Zollinger; R E Mandrell; J M Griffiss; P Altieri; S Berman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis.

Authors:  R E Mandrell; J J Kim; C M John; B W Gibson; J V Sugai; M A Apicella; J M Griffiss; R Yamasaki
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

8.  Demonstration of exopolysaccharide production by enterohemorrhagic Escherichia coli.

Authors:  A D Junkins; M P Doyle
Journal:  Curr Microbiol       Date:  1992-07       Impact factor: 2.188

9.  Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides.

Authors:  C M Tsai; R Boykins; C E Frasch
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

10.  Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus.

Authors:  C J Baker; D L Kasper; C E Davis
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.